<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ecam.oxfordjournals.org">
<title>Evidence-based Complementary and Alternative Medicine - current issue</title>
<link>http://ecam.oxfordjournals.org</link>
<description>Evidence-based Complementary and Alternative Medicine - RSS feed of current issue</description>
<prism:eIssn>1741-4288</prism:eIssn>
<prism:coverDisplayDate>June 2008</prism:coverDisplayDate>
<prism:publicationName>Evidence-based Complementary and Alternative Medicine</prism:publicationName>
<prism:issn>1741-427X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/121?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/123?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/129?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/133?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/145?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/153?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/159?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/165?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/173?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/181?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/187?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/191?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/199?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/205?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/221?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/227?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/231?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/2/237?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/121?rss=1">
<title><![CDATA[Ayurveda and eCAM: A Closer Connection]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/121?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen035</dc:identifier>
<dc:title><![CDATA[Ayurveda and eCAM: A Closer Connection]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>122</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>121</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/123?rss=1">
<title><![CDATA[Transitioning Toward Evidence-Based Research in the Health Sciences for the XXI Century]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/123?rss=1</link>
<description><![CDATA[
<p>This article discusses some of the misconceptions of evidence-based research in the health sciences. It proposes that since not all treatments in medicine and dentistry can be evidence-based, clinical applications of the evidence-based process should become a specialty. The case is particularly evident in dentistry. Therefore dentistry is taken in this article as a model for discussion. We propose that to approach dentistry from the viewpoint of the patient-oriented evidence that matters (POEM) is perfectly acceptable so far as we also engage in the process of research evaluation and appraisal in dentistry (READ). We distinguish between dentistry based on the evidence, and evidence-based dentistry. We argue that when invoking an evidence-based approach to dentistry or medicine, it is not sufficient to establish the &lsquo;levels of evidence&rsquo;, but rather that all evidence-based clinical intervention must undergo the stringent process of evidence-based research so that clinical practice guidelines be revised based on the best available evidence.</p>
]]></description>
<dc:creator><![CDATA[Chiappelli, F., Cajulis, O. S.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem123</dc:identifier>
<dc:title><![CDATA[Transitioning Toward Evidence-Based Research in the Health Sciences for the XXI Century]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>128</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>123</prism:startingPage>
<prism:section>Minireview</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/129?rss=1">
<title><![CDATA[Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part I]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/129?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Mashelkar, R. A.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen013</dc:identifier>
<dc:title><![CDATA[Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part I]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>131</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>129</prism:startingPage>
<prism:section>Lecture Series</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/133?rss=1">
<title><![CDATA[Acupuncture Treatment for Low Back Pain and Lower Limb Symptoms--The Relation between Acupuncture or Electroacupuncture Stimulation and Sciatic Nerve Blood Flow]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/133?rss=1</link>
<description><![CDATA[
<p>To investigate the clinical efficacy of acupuncture treatment for lumbar spinal canal stenosis and herniated lumbar disc and to clarify the mechanisms in an animal experiment that evaluated acupuncture on sciatic nerve blood flow. In the clinical trial, patients with lumbar spinal canal stenosis or herniated lumbar disc were divided into three treatment groups; (i) Ex-B2 (at the disordered level), (ii) electrical acupuncture (EA) on the pudendal nerve and (iii) EA at the nerve root. Primary outcome measurements were pain and dysesthesia [evaluated with a visual analogue scale (VAS)] and continuous walking distance. In the animal study, sciatic nerve blood flow was measured with laser-Doppler flowmetry at, before and during three kinds of stimulation (manual acupuncture on lumber muscle, electrical stimulation on the pudendal nerve and electrical stimulation on the sciatic nerve) in anesthetized rats. For the clinical trial, approximately half of the patients who received Ex-B2 revealed amelioration of the symptoms. EA on the pudendal nerve was effective for the symptoms which had not improved by Ex-B2. Considerable immediate and sustained relief was observed in patients who received EA at the nerve root. For the animal study, increase in sciatic nerve blood flow was observed in 56.9% of the trial with lumber muscle acupuncture, 100% with pudendal nerve stimulation and 100% with sciatic nerve stimulation. Sciatic nerve stimulation sustained the increase longer than pudendal nerve stimulation. One mechanism of action of acupuncture and electrical acupuncture stimulation could be that, in addition to its influence on the pain inhibitory system, it participates in causing a transient change in sciatic nerve blood blow, including circulation to the cauda equine and nerve root.</p>
]]></description>
<dc:creator><![CDATA[Inoue, M., Kitakoji, H., Yano, T., Ishizaki, N., Itoi, M., Katsumi, Y.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem050</dc:identifier>
<dc:title><![CDATA[Acupuncture Treatment for Low Back Pain and Lower Limb Symptoms--The Relation between Acupuncture or Electroacupuncture Stimulation and Sciatic Nerve Blood Flow]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>143</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>133</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/145?rss=1">
<title><![CDATA[Acupuncture Affects Regional Blood Flow in Various Organs]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/145?rss=1</link>
<description><![CDATA[
<p>In this review, our recent studies using anesthetized animals concerning the neural mechanisms of vasodilative effect of acupuncture-like stimulation in various organs are briefly summarized. Responses of cortical cerebral blood flow and uterine blood flow are characterized as non-segmental and segmental reflexes. Among acupuncture-like stimuli delivered to five different segmental areas of the body; afferent inputs to the brain stem (face) and to the spinal cord at the cervical (forepaw), thoracic (chest or abdomen), lumbar (hindpaw) and sacral (perineum) levels, cortical cerebral blood flow was increased by stimuli to face, forepaw and hindpaw. The afferent pathway of the responses is composed of somatic groups III and IV afferent nerves and whose efferent nerve pathway includes intrinsic cholinergic vasodilators originating in the basal forebrain. Uterine blood flow was increased by cutaneous stimulation of the hindpaw and perineal area, with perineal predominance. The afferent pathway of the response is composed of somatic group II, III and IV afferent nerves and the efferent nerve pathway includes the pelvic parasympathetic cholinergic vasodilator nerves. Furthermore, we briefly summarize vasodilative regulation of skeletal muscle blood flow via a calcitonin gene-related peptide (CGRP) induced by antidromic activation of group IV somatic afferent nerves. These findings in healthy but anesthetized animals may be applicable to understanding the neural mechanisms improving blood flow in various organs following clinical acupuncture.</p>
]]></description>
<dc:creator><![CDATA[Uchida, S., Hotta, H.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem051</dc:identifier>
<dc:title><![CDATA[Acupuncture Affects Regional Blood Flow in Various Organs]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>151</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>145</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/153?rss=1">
<title><![CDATA[Acupuncture Anesthesia and Analgesia for Clinical Acute Pain in Japan]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/153?rss=1</link>
<description><![CDATA[
<p>Acupuncture anesthesia has been practiced in China since about 1960. In Japan, Hyodo reported 30 cases of acupuncture anesthesia in 1972. However, from around 1980, the direction of acupuncture investigations turned from anesthesia to analgesia. Acupuncture analgesia is presently considered a way to activate the body's endogenous analgesic system. Recently, with the rise of acupuncture as one of the most well known CAM therapies, acupuncture or moxibustion treatment has been reported for both acute and chronic pain. Even so, few clinical reports and original articles have been reported in Japan. This review illustrates how acupuncture is being used in Japan for acute pain such as surgical operations, post- operative pain (POP), neuropathic pain, pain associated with teeth extractions and after the extraction of impacted wisdom teeth.</p>
]]></description>
<dc:creator><![CDATA[Taguchi, R.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem056</dc:identifier>
<dc:title><![CDATA[Acupuncture Anesthesia and Analgesia for Clinical Acute Pain in Japan]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>158</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>153</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/159?rss=1">
<title><![CDATA[Interaction of Aqueous Extract of Pleurotus pulmonarius (Fr.) Quel-Champ. with Glyburide in Alloxan Induced Diabetic Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/159?rss=1</link>
<description><![CDATA[
<p>Mushrooms are low calorie food with very little fat and are highly suitable for obese persons. With no starch and very low sugars, they are the &lsquo;delight of the diabetics&rsquo;. Combination of herbal drugs (or isolated phytochemicals) is found to be beneficial in certain diseases when given along with conventional drugs. The aim of the present study was to evaluate the effects of aqueous extract of <I>Pleurotus pulmonarius</I> (Lentinaceae) (called as PP-aqu) and its interaction with glyburide in alloxan induced diabetic mice. The diabetic mice treated were with PP-aqu (500 mg/kg, p.o.) alone or combination with glyburide (10 mg/kg, p.o.) for 28 days. Blood samples were collected by orbital sinus puncture using heparinized capillary glass tubes and were analyzed for serum glucose on 0, 7th, 14th, 21st and 28th days. Body weights and mortality were noted during the study period. In oral glucose tolerance test (OGTT), glucose (2.5 g/kg, p.o.) was administered with either vehicle, PP-aqu alone or in combination with glyburide and serum glucose level analyzed at 0, 30, 60 and 120 min after drug administration. Administration of PP-aqu (500 mg/kg) and its combination with glyburide (10 mg/kg) significantly (<I>P</I> &lt; 0.001) decreased serum glucose level in diabetic mice. In OGTT, glyburide or PP-aqu treatment alone or their combination produced significant (<I>P</I> &lt; 0.001) increase in glucose threshold. Thus we suggest that <I>P. pulmonarius</I> showed potent and synergistic antihyperglycemic effect in combination with glyburide.</p>
]]></description>
<dc:creator><![CDATA[Badole, S. L., Patel, N. M., Thakurdesai, P. A., Bodhankar, S. L.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem010</dc:identifier>
<dc:title><![CDATA[Interaction of Aqueous Extract of Pleurotus pulmonarius (Fr.) Quel-Champ. with Glyburide in Alloxan Induced Diabetic Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>164</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>159</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/165?rss=1">
<title><![CDATA[Cytoprotective Activity of Glycyrrhizae radix Extract Against Arsenite-induced Cytotoxicity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/165?rss=1</link>
<description><![CDATA[
<p>Licorice, <I>Glycyrrhizae radix</I>, is one of the herbal medicines in East Asia that has been commonly used for treating various diseases, including stomach disorders. This study investigated the effect of licorice on arsenite (As)-induced cytotoxicity in H4IIE cells, a rat hepatocyte-derived cell line. Cell viability was significantly diminished in As-treated H4IIE cells in a time and concentration-dependent manner. Furthermore, results from flow cytometric assay and DNA laddering in H4IIE cells showed that As treatment induced apoptotic cell death by activating caspase-3. Licorice (0.1 and 1.0 mg ml<sup>&ndash;1</sup>) treatment significantly inhibited cell death and the activity of caspase-3 in response to As exposure. These results demonstrate that licorice induced a cytoprotective effect against As-induced cell death by inhibition of caspase-3.</p>
]]></description>
<dc:creator><![CDATA[Kim, S. C., Park, S. J., Lee, J. R., Seo, J. C., Yang, C. H., Byun, S. H.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem014</dc:identifier>
<dc:title><![CDATA[Cytoprotective Activity of Glycyrrhizae radix Extract Against Arsenite-induced Cytotoxicity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>171</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>165</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/173?rss=1">
<title><![CDATA[Sopungyangjae-Tang Inhibits Development of Dermatitis in Nc/Nga Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/173?rss=1</link>
<description><![CDATA[
<p>Sopungyangjae-Tang (SYT) is a traditional Korean decoction used for the treatment of dermatitis. The aim of this study was to confirm whether or not SYT has a preventive effect on the development of atopic dermatitis in dinitrochlorobenzene-applied Nc/Nga mice. SYT was administered orally to Nc/Nga mice, which led to the remarkable suppression of the development of dermatitis, as determined by a histological examination and the serum IgE levels. Moreover, SYT inhibited the production of thymus- and activation-regulated chemokine (TARC) and its mRNA expression in a keratinocyte cell line, HaCaT, which had been stimulated with tumor necrosis factor- (TNF-) and interferon- (IFN-). Activation of the nuclear factor-B (NF-B) or activator protein-1 (AP-1) is one of the key steps in the signaling pathways mediating induction of TARC. In this study, SYT selectively suppressed NF-B activation, which may be essential for TARC expression in TNF-/IFN- treated keratinocytes. The inhibitory effect of SYT on NF-B activation and TARC production might be associated with the anti-dermatitic effects of SYT.</p>
]]></description>
<dc:creator><![CDATA[Pokharel, Y. R., Lim, S. C., Kim, S. C., Heo, T.-H., Choi, H. K., Kang, K. W.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem015</dc:identifier>
<dc:title><![CDATA[Sopungyangjae-Tang Inhibits Development of Dermatitis in Nc/Nga Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>180</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>173</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/181?rss=1">
<title><![CDATA[Evaluation of the anxiolytic effect of Nepeta persica Boiss. in mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/181?rss=1</link>
<description><![CDATA[
<p>The aim of the present study was to evaluate the anxiolytic effects of hydroalcoholic extract (HE) of <I>Nepeta persica</I> Boiss. (Lamiaceae) on the elevated plus-maze (EPM) model of anxiety. The extract of arial parts of the plant was administered intraperitoneally to male NMRI mice, at various doses, 30 min before behavioural evaluation. The HE extract of <I>N. persica</I> at the dose of 50 mg kg<sup>&ndash;1</sup> significantly increased the percentage of time spent and percentage of arm entries in the open arms of the EPM. This dose of plant extract affected neither animal's locomotor activity nor ketamine-induced sleeping time. The 50 mg kg<sup>&ndash;1</sup> dose of the plant extract seemed to be the optimal dose in producing the anxiolytic effects, lower or higher doses of the plant produce either sedative or stimulant effects. At 100 mg kg<sup>&ndash;1</sup>, the plant extract increased the locomotor activity. These results suggested that the extract of <I>N. persica</I> at dose of 50 mg kg<sup>&ndash;1</sup> possess anxiolytic effect with less sedative and hypnotic effects than that of diazepam and causes a non-specific stimulation at 100 mg kg<sup>&ndash;1</sup>.</p>
]]></description>
<dc:creator><![CDATA[Rabbani, M., Sajjadi, S. E., Mohammadi, A.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem017</dc:identifier>
<dc:title><![CDATA[Evaluation of the anxiolytic effect of Nepeta persica Boiss. in mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>186</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>181</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/187?rss=1">
<title><![CDATA[Investigation of Indian Diospyros Species for Antiplasmodial Properties]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/187?rss=1</link>
<description><![CDATA[
<p>Despite decades of intense research, malaria remains a deadly disease worldwide and new antimalarials are urgently needed due to increasing drug resistance of <I>Plasmodium falciparum</I> to existing drugs. This article reports the evaluation of four Indian <I>Diospyros</I> species viz., <I>Diospyros melanoxylon, D. peregrina, D. sylvatica, D. tomentosa</I> for antiplasmodial activities against chloroquine-sensitive (3D7) and chloroquine-resistant (K1) strains of <I>P. falciparum</I>. Six of eight methanolic extracts were found to have significant activity, (IC<SUB>50</SUB> = 16.5&ndash;92.9 &micro;g ml<sup>&ndash;1</sup>), against strain 3D7 and five of these showed similar activities against strain K1 (IC<SUB>50</SUB> = 20.5&ndash;121.6 &micro;g ml<sup>&ndash;1</sup>). <I>Diospyros sylvatica</I> was found to be the most active species (IC<SUB>50</SUB> = 16.5&ndash;29.4 &micro;g ml<sup>&ndash;1</sup>) and is worthy of further investigation.</p>
]]></description>
<dc:creator><![CDATA[Kantamreddi, V. S. S., Wright, C. W.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem019</dc:identifier>
<dc:title><![CDATA[Investigation of Indian Diospyros Species for Antiplasmodial Properties]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>190</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>187</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/191?rss=1">
<title><![CDATA[Metabolic Effects of Avocado/Soy Unsaponifiables on Articular Chondrocytes]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/191?rss=1</link>
<description><![CDATA[
<p>Avocado/soy unsaponifiable (ASU) components are reported to have a chondroprotective effect by virtue of anti-inflammatory and proanabolic effects on articular chondrocytes. The identity of the active component(s) remains unknown. In general, sterols, the major component of unsaponifiable plant material have been demonstrated to be anti-inflammatory <I>in vitro</I> and in animal models. These studies were designed to clarify whether the sterol content of ASU preparations were the primary contributors to biological activity in articular chondrocytes. ASU samples were analyzed by high pressure liquid chromatography (HPLC) and GC mass spectrometry. The sterol content was normalized between diverse samples prior to <I>in vitro</I> testing on bovine chondrocytes. Anabolic activity was monitored by uptake of 35-sulfate into proteoglycans and quantitation of labeled hydroxyproline and proline content after incubation with labeled proline. Anti-inflammatory activity was assayed by measuring reduction of interleukin-1 (IL-1)-induced synthesis of PGE2 and metalloproteases and release of label from tissue prelabeled with S-35.All ASU samples exerted a similar time-dependent up-regulation of 35-sulfate uptake in bovine cells reaching a maximum of greater than 100% after 72 h at sterol doses of 1&ndash;10 &micro;g/ml. Non-collagenous protein (NCP) and collagen synthesis were similarly up-regulated. All ASU were equally effective in dose dependently inhibiting IL-1-induced MMP-3 activity (23&ndash;37%), labeled sulfate release (15&ndash;23%) and PGE2 synthesis (45&ndash;58%). Up-regulation of glycosaminoglycan and collagen synthesis and reduction of IL-1 effects in cartilage are consistent with chondroprotective activity. The similarity of activity of ASU from diverse sources when tested at equal sterol levels suggests sterols are important for biologic effects in articular chondrocytes.</p>
]]></description>
<dc:creator><![CDATA[Lippiello, L., Nardo, J. V., Harlan, R., Chiou, T.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem132</dc:identifier>
<dc:title><![CDATA[Metabolic Effects of Avocado/Soy Unsaponifiables on Articular Chondrocytes]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>197</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>191</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/199?rss=1">
<title><![CDATA[Clinical Evaluation of Perspiration Reducing Effects of a Kampo Formula, Shigyaku-san, on Palmoplantar Hidrosis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/199?rss=1</link>
<description><![CDATA[
<p>Palmoplantar hidrosis is common in patients who are susceptible to strains on the autonomic nervous system, and stress and mental strain have been proven to produce sweating in this population. Shigyaku-san (Sini san, TJ-35: Tsumura &amp; Co.) is effective for relieving stagnation of &lsquo;liver Qi and vital energy&rsquo; in traditional Chinese medicine theory; this brings about improvement of palmoplantar hidrosis. The effect of Shigyaku-san on 40 patients was evaluated based on changes in palmoplantar sweat volume and skin temperature before and after stress loading. We also measured changes in the palmoplantar sweat volume and skin temperature due to stress load in 35 healthy controls who did not receive Shigyaku-san. Before treatment, the pre-stress sweat volume in patients was larger than that in healthy controls, however, after Shigyaku-san treatment, their pre-stress sweat volume decreased. With stress, the sweat volume increased in both patients and controls, but the net increase in the patients was larger than that in healthy controls. After Shigyaku-san treatment, the net increase of sweat volume due to stress was smaller than that of pretreatment, however, it did not show a significant difference with that of healthy controls. The palmoplantar skin temperature of the patients before treatment was lower than that of healthy controls. Palmoplantar skin temperature rose with stress loading in healthy controls, but decreased in pretreatment patients. Shigyaku-san treatment reduced the palmoplantar perspiration in palmoplantar hidrosis patients at rest and under stress. Furthermore, it also improved other serious complications, especially coldness of the extremities.</p>
]]></description>
<dc:creator><![CDATA[Ninomiya, F.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem008</dc:identifier>
<dc:title><![CDATA[Clinical Evaluation of Perspiration Reducing Effects of a Kampo Formula, Shigyaku-san, on Palmoplantar Hidrosis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>203</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>199</prism:startingPage>
<prism:section>Original Article - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/205?rss=1">
<title><![CDATA[Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human Volunteers]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/205?rss=1</link>
<description><![CDATA[
<p>We performed studies on murine models and human volunteers to examine the immunoenhancing effects of the naturally outdoor-cultivated fruit body of <I>Agaricus brasiliensis</I> KA21 (i.e. <I>Agaricus blazei</I>). Antitumor, leukocyte-enhancing, hepatopathy-alleviating and endotoxin shock-alleviating effects were found in mice. In the human study, percentage body fat, percentage visceral fat, blood cholesterol level and blood glucose level were decreased, and natural killer cell activity was increased. Taken together, the results strongly suggest that the <I>A. brasiliensis</I> fruit body is useful as a health-promoting food.</p>
]]></description>
<dc:creator><![CDATA[Liu, Y., Fukuwatari, Y., Okumura, K., Takeda, K., Ishibashi, K.-i., Furukawa, M., Ohno, N., Mori, K., Gao, M., Motoi, M.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem016</dc:identifier>
<dc:title><![CDATA[Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human Volunteers]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>219</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>205</prism:startingPage>
<prism:section>Original Article - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/221?rss=1">
<title><![CDATA[Knowledge and Attitudes about HIV/AIDS among Homoeopathic Practitioners and Educators in India]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/221?rss=1</link>
<description><![CDATA[
<p>This study is designed to assess AIDS knowledge among Homeopathy educators and physicians in India, which has not been evaluated previously. India now has the largest number of HIV infected persons worldwide, with an estimated cumulative 5.1 million infections. Homeopathy is the dominant system among the nationally-recognized alternative or complementary systems of medicine, which collectively provide health care to around 600 million people in India. Homeopathy, with its holistic and patient-centered approach, has a wide reach to people at risk of contracting human immunodeficiency virus (HIV). Participants were 68 homeopathy physicians (34 educators and 34 practitioners) who completed a CDC questionnaire measuring HIV/AIDS Knowledge regarding AIDS. This study reports the current level of knowledge of, and attitudes about, HIV/AIDS among homeopathy educators and practitioners. These findings will assist in the development of an education module to equip homeopathic health care personnel to impart accurate AIDS information and prevention counseling to their patients in an efficient manner.</p>
]]></description>
<dc:creator><![CDATA[Nyamathi, A., Singh, V. P., Lowe, A., Khurana, A., Taneja, D., George, S., Fahey, J. L.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem018</dc:identifier>
<dc:title><![CDATA[Knowledge and Attitudes about HIV/AIDS among Homoeopathic Practitioners and Educators in India]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>225</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>221</prism:startingPage>
<prism:section>Original Article - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/227?rss=1">
<title><![CDATA[Acupuncture Treatment of Dysmenorrhea Resistant to Conventional Medical Treatment]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/227?rss=1</link>
<description><![CDATA[
<p>We evaluated the effect of acupuncture on NSAID resistant dysmenorrhea related pain [measured according to Visual Analogue Scale (VAS)] in 15 consecutive patients. Pain was measured at baseline (T1), mid treatment (T2), end of treatment (T3) and 3 (T4) and 6 months (T5) after the end of treatment. Substantial reduction of pain and NSAID assumption was observed in 13 of 15 patients (87%). Pain intensity was significantly reduced with respect to baseline (average VAS = 8.5), by 64, 72, 60 or 53% at T2, T3, T4 or T5. Greater reduction of pain was observed for primary as compared with secondary dysmenorrhea. Average pain duration at baseline (2.6 days) was significantly reduced by 62, 69, 54 or 54% at T2, T3, T4 or T5. Average NSAID use was significantly reduced by 63, 74, 58 or 58% at T2, T3, T4 or T5, respectively, and ceased totally in 7 patients, still asymptomatic 6 months after treatment. Our findings suggest that acupuncture may be indicated to treat dysmenorrhea related pain, in particular in those subjects in whom NSAID or oral contraceptives are contraindicated or refused.</p>
]]></description>
<dc:creator><![CDATA[Iorno, V., Burani, R., Bianchini, B., Minelli, E., Martinelli, F., Ciatto, S.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem020</dc:identifier>
<dc:title><![CDATA[Acupuncture Treatment of Dysmenorrhea Resistant to Conventional Medical Treatment]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>230</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>227</prism:startingPage>
<prism:section>Original Article - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/231?rss=1">
<title><![CDATA[Patterns of Using Complementary and Alternative Medicine by Stroke Patients at Two University Hospitals in Korea]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/231?rss=1</link>
<description><![CDATA[
<p>This study measured the prevalence of complementary and alternative medicine (CAM) use among Korean stroke patients. Questionnaire-based 20-min interviews were conducted at the hospitals by a trained nurse after an outpatient visit. It included questions on demographic information, clinical information and the utilization of CAM. Of 304 stroke-patient respondents, 164 (54%) had used CAM, of which 66% had started taking CAM products following suggestions from family members and other relatives. Of the 57% of users who felt that CAM was effective, 84% considered that it improved the symptoms of stroke and 16% felt it was effective in achieving psychological relaxation. Of the eight CAM categories used by respondents, 92% used traditional Oriental medical treatments, 36% used plant- and animal-derived over-the-counter health care products, 24% used minerals and vitamins, and 11% used manual therapies. The majority of stroke patients (68%) were trying a new type of CAM, and half of the respondents (45%) relied on the knowledge of their general practitioner about CAMs when deciding whether to use them. Most of the stroke patients in this study used CAM, and a half of them reported beneficial effects. Despite the presence of adverse side effects, they tended to be used without discussion with chief physicians, and hence physicians should be actively involved in the usage of CAM.</p>
]]></description>
<dc:creator><![CDATA[Shin, Y.-I., Yang, C.-Y., Joo, M.-C., Lee, S.-G., Kim, J.-H., Lee, M. S.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem025</dc:identifier>
<dc:title><![CDATA[Patterns of Using Complementary and Alternative Medicine by Stroke Patients at Two University Hospitals in Korea]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>235</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>231</prism:startingPage>
<prism:section>Original Article - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/2/237?rss=1">
<title><![CDATA[Acupuncture Research: Strategies for Clinical Evaluation: Workshop Report, York, July 5-8, 2006]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/2/237?rss=1</link>
<description><![CDATA[
<p>This report summarizes a ground-breaking workshop on the strategic direction of acupuncture research which was held in York in early July 2006. Three days were spent discussing the history, the philosophy and the practicalities of researching acupuncture. Attending the workshop were an international group of researchers with varied backgrounds, including acupuncturists, physicians, physiotherapists, sociologists and anthropologists. Supported by the Medical Research Council's Health Services Research Collaboration, Elsevier and others, this workshop was an opportunity to brainstorm the issues and to the concerns in the field and set out directions for research that would tackle some of the major challenges facing the acupuncture research community.</p>
]]></description>
<dc:creator><![CDATA[Hopwood, V., MacPherson, H.]]></dc:creator>
<dc:date>2008-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem028</dc:identifier>
<dc:title><![CDATA[Acupuncture Research: Strategies for Clinical Evaluation: Workshop Report, York, July 5-8, 2006]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>240</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>237</prism:startingPage>
<prism:section>Meeting Report</prism:section>
</item>

</rdf:RDF>